SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-18-016442
Filing Date
2018-03-22
Accepted
2018-03-22 16:45:49
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tv488264_s3.htm S-3 208681
2 EXHIBIT 5.1 tv488264_ex5-1.htm EX-5.1 17045
3 EXHIBIT 23.1 tv488264_ex23-1.htm EX-23.1 2689
4 EXHIBIT 23.2 tv488264_ex23-2.htm EX-23.2 2118
5 GRAPHIC tv488264_ex5-1img1.jpg GRAPHIC 7737
6 GRAPHIC tv488264_ex5-1img2.jpg GRAPHIC 6769
7 GRAPHIC tv488264_ex5-1img3.jpg GRAPHIC 5586
8 GRAPHIC tv488264_logo.jpg GRAPHIC 10412
  Complete submission text file 0001144204-18-016442.txt   274204
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-223856 | Film No.: 18707441
SIC: 8731 Services-Commercial Physical & Biological Research